http://rdf.ncbi.nlm.nih.gov/pubchem/reference/29794125

Outgoing Links

Predicate Object
contentType Journal Article
issn 2234-943X
pageRange 637186-
publicationName Frontiers in Oncology
startingPage 637186
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_332e414602a4f905c4c7f577007d1bb1
bibliographicCitation Puzzolo MC, Del Giudice I, Peragine N, Mariglia P, De Propris MS, Cappelli LV, Trentin L, Reda G, Cuneo A, Molica S, Piciocchi A, Arena V, Mauro FR, Guarini A, Foà R. TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia. Front Oncol. 2021;11():637186. PMID: 33937038; PMCID: PMC8082026.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2782-2752
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc918506d959a124d1040905e9af3d2d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b6e665733848e7b557897d33b9cc1b41
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06af91edc7d539c794103766c82fdeee
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3308cd07e1028505fa5ac6624ee5cb84
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c12e8be7a3cedfd3d4c4d5e457e902ad
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1889ba0b75e893e43b9537e0ff195861
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c72c9cc460b9e1ced3592a34938d4ea5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5f9c25365efdd43a598e43e3f7ac143
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9138bbc7e61357f1894a16122062bf2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f82c75d36d28afddb136875adbc1a524
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_588db14f65904f66db015e4f2ea0959d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1222-6149
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_649c578df04500c030a4545f3d295a5f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09de08e5de0dcb78435d3579093e3a43
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6864-9533
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7de1e3b2526afd989f962227ae137663
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cec4c06f455d1783260eb6b8da46e883
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8648-885X
date 2021-04-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/PMC8082026
https://doi.org/10.3389/fonc.2021.637186
https://pubmed.ncbi.nlm.nih.gov/33937038
isPartOf https://portal.issn.org/resource/ISSN/2234-943X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39509
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title TH2/TH1 Shift Under Ibrutinib Treatment in Chronic Lymphocytic Leukemia
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9720
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8cb7e80809cc72f74cddd6d498451b46
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_69c8365c5e015aa60518d03ac8157056
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0d1c0203c86182a45fb1c6272bbe1d33
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_564f64348efdade903a3b83a985759d0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_118dd6abf266102dccb53d8fc658affb
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24821094
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Showing number of triples: 1 to 45 of 45.